Stifel Nicolaus is out with its report today on Five Star Quality Care FVE, lowering its PT from $7 to $6.50.
In a note to clients, Stifel Nicolaus writes, "We continue to see upside from FVE's current $5.02 share price but are lowering our target from $7 to $6.50 based on reduced estimates and lower DCF. Our revised target price is 7.3x our 2012E CFFO per share and 10.1x 2012E adj. EV/EBITDAR. FVE shares still offer 29% upside to our revised target price."
Stifel Nicolaus maintains Buy on FVE.
At the time of posting, shares of FVE were trading at $4.97, down 1.00% from Thursday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in